| إسم المؤهل | جامعة المؤهل | تاريخ المؤهل |
|---|---|---|
| الدكتوراه في Cancer biology | State University of New York at Buffalo | 06/01/1444 |
| اسم البحث | تاريخ تقديم البحث | رابط البحث |
|---|---|---|
| Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer | 1444-04-07 12:00:00 ص | Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer |
| Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases | 1443-11-02 12:00:00 ص | Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases |
| FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with | 1443-09-30 12:00:00 ص | FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with |
| Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1?, HIF2?, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | 1442-12-22 12:00:00 ص | Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1?, HIF2?, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma |
| Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX | 1442-11-21 12:00:00 ص | Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX |
| Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? | 1440-11-29 12:00:00 ص | Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? |
| Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs | 1439-06-13 12:00:00 ص | Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs |
| Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors | 1438-09-06 12:00:00 ص | Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors |
| إسم الجهة | الخبرة | من | إلي |
|---|
| إسم الدورة | المكان | تاريخ الدورة |
|---|---|---|
| O EFFECTIVE TEACHING WORKSHOP SERIES, CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSA), UNIVERSITY AT BUFFALO. | 15/01/1442 | |
| O ACADEMIC LEADERSHIP DEVELOPMENT WORKSHOP, ACADEMIC LEADERSHIP CENTER, MINISTRY OF EDUCATION AT KINGDOM OF SAUDI ARABIA, WASHINGTON D.C. | Ministry of Education | 11/09/1440 |
| O STATISTICAL WORKSHOP SERIES, CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSA), UNIVERSITY AT BUFFALO. | 27/11/1439 |
| الجائزة/براءة الاختراع | الجهة المانحة | التاريخ |
|---|
| مسمي اللجنة | نوع اللجنة | تاريخ الإنضمام |
|---|---|---|
| لجنة الأنشطة الطلابية | داخل الجامعة | 08/02/1444 |
| ملف السيرة الذاتية |
|---|